• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Possible genetic marker for type 2 diabetes in Latinos identified

byJohn PrendergassandPriyanka Vedak
June 14, 2014
in Chronic Disease, Endocrinology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A missense variant of hepatocyte nuclear factor 1-alpha (HNF1A) gene was associated with an increased prevalence of type 2 diabetes in Latino populations.

2 .Compared to non-carriers, carriers of this missense variant did not demonstrate an earlier age of onset of type 2 diabetes.                                                   

Evidence Rating Level: 2 (Good) 

Study Rundown: Type 2 diabetes is a condition in which the body does not react properly to insulin being secreted by the β cells of the pancreas. This results in elevated blood glucose levels and usually manifests as increased appetite, weight loss, loss of sensation in the extremities, and ultimately death. Diet and weight are two of the largest risk factors for this form of diabetes. However, certain genetic markers and race have also been shown to play a part in diabetes risk. Currently, Mexican-American adults demonstrate a type 2 diabetes prevalence of 10% while Caucasian Americans demonstrate a prevalence of 5.2%. The goal of this study was to identify protein-coding genetic variants associated with diabetes in the Latino-American population.

The authors of this study were able to detect a genetic variant in the MODY3 (maturity onset diabetes of the young type 3)-causing gene HNF1A (hepatocyte nuclear factor 1- alpha) that was associated with the incidence of type 2 diabetes in the Latino community. While this is the largest study of its kind thus far, the sample size was still not sufficient for the detection of gene-variants at frequencies lower than 1%. The implications of this study are nevertheless far-reaching; With further research, clinicians may eventually be capable of making an earlier diagnosis of type 2 diabetes, thereby allowing for earlier patient education on lifestyle and risk factor modification, as well as earlier treatment initiation.

Click to read the study in JAMA

RELATED REPORTS

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

2 Minute Medicine Rewind March 23, 2026

Relevant Reading: Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population

In-Depth [cross-sectional study]: 3756 Mexican and US Latino participants (1794 with type 2 diabetes and 1962 without) were recruited from 1993 until 2013. Ancestry was determined based on self-report and confirmed using genotype data. Those diagnosed with type 2 diabetes met the criteria for diagnosis set forth by the American Diabetes Association. Whole genome sequencing was performed on study participants. A single missense mutation, p.E508K, was noted to occur in  association with type 2 diabetes (odds ratio, 5.45; 95%CI, 2.83-10.61). No difference in the mean age of diabetes onset for variant carriers versus non-carriers was observed (45.3 years versus 47.5 years, P=.49).

More from this author: Reducing surgical complications may increase costs,Protected sleep periods improve intern alertness and sleep duration,ADHD medication decreases rates of criminality in ADHD patients,Low dose aspirin shows net clinical benefit in patients with first unprovoked venous thromboembolism, Rare TREM-2 mutation implicated in Alzheimer’s Disease 

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: diabetestype 2 diabetes
Previous Post

PTSD and major depressive episode linked with preterm birth

Next Post

Contraceptive prior to first intercourse linked with improved reproductive outcomes

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

April 3, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026
Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome
Weekly Rewinds

2 Minute Medicine Rewind January 19, 2026

January 19, 2026
Next Post
Clinic intervention reduces pregnancy risk behaviors in vulnerable youth

Contraceptive prior to first intercourse linked with improved reproductive outcomes

Palliative chemotherapy associated with more ICU treatment at end-of-life

Targeting Children’s Asthma Care measures reduced asthma readmission rates

Primary care and specialists have comparable outcomes in treating Sleep Apnea

2 Minute Medicine Rewind June 9 – June 15, 2014

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A multidisciplinary home-based intervention may reduce risk of falls after stroke
  • Prednisone may have bone and cardiovascular benefits compared to hydrocortisone therapy in adrenal insufficiency
  • Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.